Indoleamine 2,3 dioxygenase and metabolic control of immune responses

Munn, David H., Mellor, Andrew L.·2013·Trends in Immunology
DOI 10.1016/j.it.2012.10.001

Cited by (1,000)

Items 101–200 of 1,000

  1. Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
    Yang Chen, Yaran Wu, Hongying Yang, Xin‐Zhe Li, Mengmeng Jie, Chang-jiang Hu, Yuyun Wu, Shiming Yang, Yingbin Yang · 2018 · Cell Death and Disease
  2. Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling
    Teng Huang, Jia Ge Song, Jia Li Gao, Jia Rong Cheng, Hao Xie, Lu Zhang, Yuhan Wang, Zhichao Gao, Xiaohui Wang, Xiaohui Wang et al. · 2022 · Nature Communications
  3. Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
    Freek J. H. Sorgdrager, Yannick Vermeiren, Martijn H. J. R. van Faassen, Claude van der Ley, Ellen A. A. Nollen, Ido P. Kema, Peter Paul De Deyn · 2019 · Journal of Neurochemistry
  4. Physiological roles of tryptophan in teleosts: current knowledge and perspectives for future studies
    Seyyed Morteza Hoseini, Amalia Pérez‐Jiménez, Benjamín Costas, Rita Azeredo, Manuel Gesto · 2017 · Reviews in Aquaculture
  5. High-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometry
    Filippos Porichis, Meghan G. Hart, Morgane Griesbeck, Holly L. Everett, Muska Hassan, Amy E. Baxter, Madelene Lindqvist, Sara M. Miller, Damien Z. Soghoian, Daniel G. Kavanagh et al. · 2014 · Nature Communications
  6. Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis
    Wu, Wan-fu, Tan, Xin-jie, Dai, Yu-bing, Krishnan, Venkatesh, Warner, Margaret, Gustafsson, Jan-Åke · 2013 · Proceedings of the National Academy of Sciences
  7. B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner
    Alexandre Nouël, Pierre Pochard, Quentin Simon, Isabelle Segalen, Yannick Le Meur, Jacques‐Olivier Pers, Sophie Hillion · 2015 · Journal of Autoimmunity
  8. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
    Yi Wang, Yuya Wang, Yifei Ren, Qi Zhang, Ping Yi, Chunming Cheng · 2022 · Seminars in Cancer Biology
  9. Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
    Howard Eliot Gendelman, Yuning Zhang, Pamela M. Santamaria, Katherine E. Olson, Charles R. Schutt, Danish Bhatti, Bhagya Laxmi Dyavar Shetty, Yaman Lu, Katherine A. Estes, David G. Standaert et al. · 2017 · npj Parkinson s Disease
  10. Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
    Qiaohong Wang, Xia Wu · 2017 · International Immunopharmacology
  11. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
    Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez · 2019 · Seminars in Cancer Biology
  12. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment
    Jayashree Dolpady, Chiara Sorini, Caterina Di Pietro, Ilaria Cosorich, Roberto Ferrarese, Diego Saita, Massimo Clementi, Filippo Canducci, Marika Falcone · 2015 · Journal of Diabetes Research
  13. Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1 H -indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate
    Stefano Crosignani, Patrick Bingham, Pauline Bottemanne, Hélène Cannelle, Sandra Cauwenberghs, Marie Cordonnier, Deepak Dalvie, Frederik D. Deroose, Jun Li Feng, Bruno Gomes et al. · 2017 · Journal of Medicinal Chemistry
  14. Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms
    Tiana Kordbacheh, Jamie Honeychurch, Fiona Helen Blackhall, Corinne Faivre Finn, Tim Illidge · 2017 · Annals of Oncology
  15. Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease
    Abigail Raffner Basson, Ashley Trotter, Alexander Rodriguez‐Palacios, Fabio Cominelli · 2016 · Frontiers in Immunology
  16. Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy
    Charlotte de Wolf, Marja van de Bovenkamp, Marcel H. N. Hoefnagel · 2017 · Cytotherapy
  17. Tryptophan‐derived serotonin‐kynurenine balance in immune activation and intestinal inflammation
    Sabah Haq, Jensine A. Grondin, Waliul Islam Khan · 2021 · The FASEB Journal
  18. Hypoxia and Mucosal Inflammation
    Sean P. Colgan, Eric L. Campbell, Douglas J. Kominsky · 2016 · Annual Review of Pathology Mechanisms of Disease
  19. Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic options
    Melina Mescher, Thomas Haarmann‐Stemmann · 2018 · Pharmacology & Therapeutics
  20. Niacin
    James B. Kirkland, Mirella L. Meyer‐Ficca · 2018 · Advances in food and nutrition research
  21. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy
    Lei Lei, Dennis Huang, Huile Gao, Bin He, Jun Cao, Nicholas A. Peppas · 2022 · Science Advances
  22. Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
    Li, Dan, Yu, Shuang, Long, Yu, Shi, Ai, Deng, Jie, Ma, Yin, Wen, Jing, Li, Xiaoqiu, Liu, Songyu, Zhang, Yulu et al. · 2022 · Frontiers in Immunology
  23. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection
    Mohammad-Ali Jenabian, Mohamed El Far, Kishanda Vyboh, Ido P. Kema, Cecilia Theresa Costiniuk, Réjean Thomas, Jean-Guy Baril, Roger P. LeBlanc, Cynthia Kanagaratham, Danuta Radzioch et al. · 2015 · The Journal of Infectious Diseases
  24. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
    Yun Liu, Jianfeng Guo, Leaf Huang · 2020 · Theranostics
  25. The immune system and microbiome in pregnancy
    Gwenny Manel Fuhler · 2020 · Best Practice & Research Clinical Gastroenterology
  26. Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
    Florent Peyraud, Jean‐Philippe Guégan, D. Bodet, Sophie Cousin, Alban Bessede, Antoîne Italiano · 2022 · Frontiers in Immunology
  27. Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
    Anke Vanderstraeten, C. Luyten, Godelieve Verbist, Sandra Tuyaerts, Frédéric C. Amant · 2014 · Cancer Immunology Immunotherapy
  28. Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis
    Joan Clària, Richard Moreau, François Fenaille, Àlex Amorós, Christophe Junot, Henning Grønbæk, Minneke J. Coenraad, Alain Pruvost, Aurélie Ghettas, Emeline Chu‐Van et al. · 2018 · Hepatology
  29. Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers
    Subrata Debnath, Chakradhar Velagapudi, Laney Redus, Farook Thameem, Balakuntalam S. Kasinath, Claudia Hura, Carlos Lorenzo, Hanna E. Abboud, Jason C. O’Connor · 2017 · International Journal of Tryptophan Research
  30. Indoleamine 2, 3-dioxygenase regulation of immune response (Review)
    Hao Wu, Jianping Gong, Yong Liu · 2018 · Molecular Medicine Reports
  31. Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
    Vikram Mehraj, Jean‐Pierre Routy · 2015 · International Journal of Tryptophan Research
  32. Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
    Piera Gargiulo, Chiara Della Pepa, Simona Berardi, Daniela Califano, Stefania Scala, Luigi Buonaguro, Gennaro Ciliberto, Peter Brauchli, Sandro Pignata · 2016 · Cancer Treatment Reviews
  33. Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Mengke Niu, Ming Yi, Ning Li, Suxia Luo, Kongming Wu · 2021 · Experimental Hematology and Oncology
  34. Antigen-specific regulatory T-cell responses to intestinal microbiota
    Emilie V. Russler-Germain, Sunaina Rengarajan, C-S Hsieh · 2017 · Mucosal Immunology
  35. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage
    Florian Reizine, Mathieu Lesouhaitier, Murielle Grégoire, Kieran Pinceaux, Arnaud Gacouin, Adel Maamar, Benoît Painvin, Christophe Camus, Yves Le Tulzo, Pierre Tattevin et al. · 2021 · Journal of Clinical Immunology
  36. Inflammatory and Immune Responses in the Arterial Media
    George Tellides, Jordan S. Pober · 2015 · Circulation Research
  37. Amino Acids As Mediators of Metabolic Cross Talk between Host and Pathogen
    Wenkai Ren, Ranjith Rajendran, Yuanyuan Zhao, Bie Tan, Guoyao Wu, Fuller W. Bazer, Guoqiang Zhu, Yuanyi Peng, Xiaoshan Huang, Jinping Deng et al. · 2018 · Frontiers in Immunology
  38. Indoleamine 2,3 dioxygenase in intestinal disease
    Matthew A. Ciorba · 2012 · Current Opinion in Gastroenterology
  39. The Role of Placental Tryptophan Catabolism
    Peter Sedlmayr, Astrid Blaschitz, Roland Stocker · 2014 · Frontiers in Immunology
  40. Allergen Recognition by Innate Immune Cells: Critical Role of Dendritic and Epithelial Cells
    Fabián Salazar, Amir M. Ghaemmaghami · 2013 · Frontiers in Immunology
  41. ATF4 Regulates CD4+ T Cell Immune Responses through Metabolic Reprogramming
    Xi Yang, Rui Xia, Cuihua Yue, Wensi Zhai, Wenwen Du, Qianting Yang, Huiling Cao, Xiaojuan Chen, Danielle Obando, Yibei Zhu et al. · 2018 · Cell Reports
  42. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer
    Shawn P. Kubli, Christian Bassi, Cecilia Roux, Andrew C. Wakeham, Christoph Göbl, Wenjing Zhou, Soode Moghadas Jafari, Bryan E. Snow, Lisa Jones, Luís Palomero et al. · 2019 · Proceedings of the National Academy of Sciences
  43. Kynurenine pathway in Parkinson's disease—An update
    Dhivya Venkatesan, Mahalaxmi Iyer, Arul Narayanasamy, Kamalakannan Siva, Balachandar Vellingiri · 2020 · eNeurologicalSci
  44. Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment
    Simon Schreiber, Christoph Matthias Hammers, Achim J. Kaasch, Burkhart L. Schraven, Anne Dudeck, Sascha Kahlfuß · 2021 · Frontiers in Immunology
  45. Metabolic interplays between the tumour and the host shape the tumour macroenvironment
    Patricia Altea‐Manzano, Amanda R. Decker-Farrell, Tobias Janowitz, Ayelet Erez · 2025 · Nature reviews. Cancer
  46. Post‐transcriptional regulatory networks in immunity
    Pavel V. Ivanov, Paul J. Anderson · 2013 · Immunological Reviews
  47. Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration
    Joseph E. Qualls, Peter J. Murray · 2015 · Seminars in Immunopathology
  48. The IDO–AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection
    Eliseu Frank de Araújo, Cláudia Feriotti, Nayane Alves de Lima Galdino, Nycolas Willian Preite, Vera Lúcia Garcia Calich, Flávio V. Loures · 2017 · Frontiers in Immunology
  49. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
    Xue‐Song Zhang, Jackie Li, Kimberly A. Krautkramer, Michelle H. Badri, Thomas Battaglia, Timothy C. Borbet, Hyunwook Koh, Sandy Ng, Rachel A. Sibley, Yuanyuan Li et al. · 2018 · eLife
  50. Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
    Valentina Folgiero, Bianca Maria Goffredo, Perla Filippini, Riccardo Masetti, Giuseppina Bonanno, Roberta Caruso, Valentina Bertaina, Angela Mastronuzzi, Stefania Gaspari, Marco Zecca et al. · 2013 · Oncotarget
  51. Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase
    Ariel Lewis-Ballester, F. Forouhar, Sung-Mi Kim, Scott Lew, Yongqiang Wang, Shay Karkashon, J. Seetharaman, Dipanwita Batabyal, Bing‐Yu Chiang, Munif Hussain et al. · 2016 · Scientific Reports
  52. Interplay between Immune Checkpoint Proteins and Cellular Metabolism
    Sangbin Lim, Joshua B. Phillips, Luciana Madeira da Silva, Ming Zhou, Øystein Fodstad, Laurie B. Owen, Ming Tan · 2017 · Cancer Research
  53. Molecular Targets of Natural Compounds with Anti-Cancer Properties
    Małgorzata Kubczak, Aleksandra Szustka, Małgorzata Rogalińska · 2021 · International Journal of Molecular Sciences
  54. Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
    Mohammad-Ali Jenabian, Mital Patel, Ido P. Kema, Cynthia Kanagaratham, Danuta Radzioch, Paméla Thébault, Réjean Lapointe, Cecile L. Tremblay, Norbert J. Gilmore, Petronela Ancuța et al. · 2013 · PLoS ONE
  55. Metabolic Regulation of Cell Fate and Function
    Shohini K. Ghosh-Choudhary, Jie Liu, Toren Finkel · 2020 · Trends in Cell Biology
  56. The pathogenesis of nephropathia epidemica: New knowledge and unanswered questions
    Jukka T. Mustonen, Satu Mäkelä, Tuula K. Outinen, Outi Laine, Juulia Jylhävä, Petteri T. Arstila, Mikko Hurme, Antti I. Vaheri · 2013 · Antiviral Research
  57. COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
    Marek Ostaszewski, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert D. Phair, Aurelio Orta Resendiz, Vidisha Singh, Sara Sadat Aghamiri, Márcio Luís Acencio, Enrico Glaab et al. · 2021 · Molecular Systems Biology
  58. T Cells and Cancer: How Metabolism Shapes Immunity
    Barbara Molon, Bianca Calì, Antonella Viola · 2016 · Frontiers in Immunology
  59. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
    Yang Li, Nan Hu, Dan Yang, Gregory F. Oxenkrug, Qing Yang · 2017 · FEBS Journal
  60. A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
    Rebecca Sophie Kristeleit, Ірина Давиденко, Vadim Shirinkin, Fatima El-Khouly, Igor Bondarenko, Michael Joseph Goodheart, В. А. Горбунова, Carol A. Penning, Jack G. Shi, Xiangdong Liu et al. · 2017 · Gynecologic Oncology
  61. Metabolic host response and therapeutic approaches to influenza infection
    Mohsen Keshavarz, Farid Solaymani‐Mohammadi, Haideh Namdari, Yaser Arjeini, Mohammad Javad Mousavi, Farhad Rezaei · 2020 · Cellular & Molecular Biology Letters
  62. Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function
    Hyung‐Ran Kim, Anbok Lee, Eun-Jeong Choi, Min-Pyo Hong, Jeong Hae Kie, Woosung Lim, Hyeon Kook Lee, Byung‐In Moon, Ju‐Young Seoh · 2014 · PLoS ONE
  63. Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes
    Barbara Strasser, Daniela Geiger, Markus Schauer, Hannes Gatterer, Martin Burtscher, Dietmar Fuchs · 2016 · PLoS ONE
  64. Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence
    Biagio Ricciuti, Giulia Costanza Leonardi, Paolo Puccetti, Francesca Fallarino, Vanessa Bianconi, Amirhossein Sahebkar, Sara Baglivo, Rita Chiari, Matteo Pirro · 2018 · Pharmacology & Therapeutics
  65. L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis
    Jianxin Cui, Xian-Hui Xu, Tao He, Jia-Jia Liu, Tian-Yu Xie, Wen Tian, Jun-Yan Liu · 2023 · Journal of Experimental & Clinical Cancer Research
  66. Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
    Keishi Adachi, Koji Tamada · 2015 · Cancer Science
  67. Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function
    Eliana Ribechini, James A. Hutchinson, Sabine Hergovits, Marion Heuer, Jörg Lucas, Ulrike Schleicher, Ana-Laura Jordán Garrote, Sarah J. Potter, Paloma Riquelme, Heike Brackmann et al. · 2017 · Blood Advances
  68. Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival
    Debbie M. Ferns, Ido P. Kema, Marrije R. Buist, Hans W. Nijman, Gemma G. Kenter, Ekaterina S. Jordanova · 2015 · OncoImmunology
  69. Can we predict tuberculosis cure? What tools are available?
    Delia Goletti, Cecilia S. Lindestam Arlehamn, Thomas J. Scriba, Richard M. Anthony, Daniela María Cirillo, Tonino Alonzi, Claudia Maria Denkinger, Frank G. J. Cobelens · 2018 · European Respiratory Journal
  70. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe−/− mice
    Konstantinos A. Polyzos, О. А. Овчинникова, M Berg, Roland Baumgartner, Hanna E. Agardh, John Pirault, Anton Gisterå, Alice Assinger, Andrés Laguna-Fernández, Magnus Bäck et al. · 2015 · Cardiovascular Research
  71. Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
    Roberta Mancuso, Ambra Hernis, Simone Agostini, Marco Rovaris, Domenico Caputo, Dietmar Fuchs, Mario Clerici · 2015 · PLoS ONE
  72. Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications
    Horacio Rilo, Joaquin A. Cagliani, Daniel A. Grande, Ernesto P. Molmenti, Edmund J. Miller · 2017 · Journal of Stem Cell and Regenerative Biology
  73. IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1
    Erik A. Dill, Patrick Michael Dillon, Timothy N. J. Bullock, Anne M. Mills · 2018 · Modern Pathology
  74. Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes
    Božidarka L. Zarić, Jelena Radovanović, Zoran M. Gluvic, Alan James Stewart, Magbubah Essack, Olaa Motwalli, Takashi Gojobori, Esma R. Isenović · 2020 · Frontiers in Immunology
  75. Inflammation‐induced activation of the indoleamine 2,3‐dioxygenase pathway: Relevance to cancer‐related fatigue
    Sangmi Kim, Brian J. Miller, Michael Edward Stefanek, Andrew H. Miller · 2015 · Cancer
  76. Activation of the STING Adaptor Attenuates Experimental Autoimmune Encephalitis
    Henrique de Paula Lemos, Lei Huang, Phillip Chandler, Eslam T. Mohamed, Guilherme Rabelo de Souza, Lingqian Li, Gabriela A. Pacholczyk, Glen N. Barber, Yoshihiro Hayakawa, David H. Munn et al. · 2014 · The Journal of Immunology
  77. Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease
    Renáta Gáspár, Dóra Halmi, Virág Demján, Róbert Berkecz, Márton Pipicz, Tamás Csont · 2022 · Frontiers in Immunology
  78. Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases
    Chuan Huang, Hao‐Xian Zhu, Yuan Yao, Zhen-Hua Bian, Yu-Jian Zheng, Liang Li, Haralampos Μ. Moutsopoulos, Merrill Eric Gershwin, Zhe‐Xiong Lian · 2019 · Journal of Autoimmunity
  79. Tryptophan: A Unique Role in the Critically Ill
    Marcela Káňová, Pavel Kohout · 2021 · International Journal of Molecular Sciences
  80. Catalytic Mechanism of Cofactor-Free Dioxygenases and How They Circumvent Spin-Forbidden Oxygenation of Their Substrates
    Aitor Hernández‐Ortega, Matthew G. Quesne, Soi Bui, Derren J. Heyes, Roberto A. Steiner, Nigel Shaun Scrutton, Sam P. de Visser · 2015 · Journal of the American Chemical Society
  81. Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
    Paolo Puccetti, Francesca Fallarino, Antoîne Italiano, Isabelle Soubeyran, Gaëtan Marie MacGrogan, Marc Debled, Valérie Velasco, D. Bodet, Sandrine Eimer, Marc Veldhoen et al. · 2015 · PLoS ONE
  82. Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
    Galbraith, Matthew D., Rachubinski, Angela L., Smith, Keith P., Araya, Paula, Waugh, Katherine A., Enriquez-Estrada, Belinda, Worek, Kayleigh, Granrath, Ross E., Kinning, Kohl T., Paul Eduthan, Neetha et al. · 2023 · Science Advances
  83. Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi
    Luigina R. Romani, Teresa Zelante, Antonella DE LUCA, Rossana Giulietta Iannitti, Silvia Moretti, Andréa Bartoli, Franco Aversa, Paolo Puccetti · 2014 · European Journal of Immunology
  84. Same yet different — how lymph node heterogeneity affects immune responses
    Paulina Cruz de Casas, Konrad Knöpper, Rupak Dey Sarkar, Wolfgang Kastenmüller · 2023 · Nature reviews. Immunology
  85. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
    Dávid Dóra, Christopher J. Rivard, Hui Yu, Paul A. Bunn, Kenichi Suda, Shengxiang Ren, Shivaun Lueke Pickard, Viktória László, Tünde Harkó, Zsolt Megyesfalvi et al. · 2020 · Molecular Oncology
  86. Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
    James A. Ankrum, Riddhi G. Dastidar, Joon Faii Ong, Oren Levy, Jeffrey M. Karp · 2014 · Scientific Reports
  87. Breast Cancer Heterogeneity and Response to Novel Therapeutics
    Mariona Baliu‐Piqué, Atanasio Pandiella, Alberto Ocaña · 2020 · Cancers
  88. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state
    Till Adhikary, Annika Wortmann, Tim Schumann, Florian Finkernagel, Sonja Lieber, Katrin Sabine Roth, Philipp M. Toth, Wibke E. Diederich, Andrea Nist, Thorsten Stiewe et al. · 2015 · Nucleic Acids Research
  89. Immune checkpoint modulation: Rational design of combination strategies
    Dmitriy Zamarin, Michael A. Postow · 2015 · Pharmacology & Therapeutics
  90. The bridge of the gut–joint axis: Gut microbial metabolites in rheumatoid arthritis
    Xiaoyu Xu, Miao Wang, Zikang Wang, Qian Chen, Xixuan Chen, Yingyue Xu, Min Dai, Bin Wu, Yanping Li · 2022 · Frontiers in Immunology
  91. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
    Yue Zheng, Yiran Yao, Tongxin Ge, Shengfang Ge, Renbing Jia, Xin Song, Ai Zhuang · 2023 · Journal of Experimental & Clinical Cancer Research
  92. Lifting the innate immune barriers to antitumor immunity
    Carla Vanina Rothlin, Sourav Ghosh · 2020 · Journal for ImmunoTherapy of Cancer
  93. Stress Kinase GCN2 Controls the Proliferative Fitness and Trafficking of Cytotoxic T Cells Independent of Environmental Amino Acid Sensing
    Lee-Ann Van de Velde, Xi-zhi J. Guo, Lidija Barbaric, Amber M. Smith, Thomas H. Oguin, Paul Glyndwr Thomas, Peter J. Murray · 2016 · Cell Reports
  94. The tolerogenic role of IFN-γ
    Primož J. Rožman, Urban Švajger · 2018 · Cytokine & Growth Factor Reviews
  95. Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
    Woong-Jai Won, Jessy S. Deshane, Jianmei Wu Leavenworth, Claudia R. Oliva, Corinne E. Griguer · 2019 · Cell Stress
  96. Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation
    Emily R. Thompson, Lucy Bates, Ibrahim Ibrahim, Avinash Sewpaul, Ben Stenberg, Andrew McNeill, Rodrigo Figueiredo, T Girdlestone, Georgina C. Wilkins, Ellen A. Irwin et al. · 2020 · American Journal of Transplantation
  97. Innate Immune Mechanisms to Protect Against Infection at the Human Decidual-Placental Interface
    Regina Hoo, Annettee Nakimuli, Roser Vento‐Tormo · 2020 · Frontiers in Immunology
  98. Aminoacyl-tRNA synthetases and amino acid signaling
    Ya Chun Yu, Jung Min Han, Sung‐Hoon Kim · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  99. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19)
    İmdat Eroğlu, Burcu Çelik Eroğlu, Gulay Sain Guven · 2021 · Nutrition
  100. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
    Urszula Kozłowska, Charles David Nichols, Kalina Wiatr, Maciej Figiel · 2021 · Journal of Neurochemistry